What Does Intersect ENT, Inc.'s (NASDAQ:XENT) Share Price Indicate?

Simply Wall St
·3 min read

Intersect ENT, Inc. (NASDAQ:XENT), is not the largest company out there, but it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGM. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. But what if there is still an opportunity to buy? Let’s examine Intersect ENT’s valuation and outlook in more detail to determine if there’s still a bargain opportunity.

Check out our latest analysis for Intersect ENT

What is Intersect ENT worth?

Intersect ENT appears to be overvalued by 22% at the moment, based on my discounted cash flow valuation. The stock is currently priced at US$24.00 on the market compared to my intrinsic value of $19.66. This means that the buying opportunity has probably disappeared for now. But, is there another opportunity to buy low in the future? Given that Intersect ENT’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.

Can we expect growth from Intersect ENT?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 48% over the next couple of years, the future seems bright for Intersect ENT. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? It seems like the market has well and truly priced in XENT’s positive outlook, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe XENT should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping tabs on XENT for some time, now may not be the best time to enter into the stock. The price has surpassed its true value, which means there’s no upside from mispricing. However, the optimistic prospect is encouraging for XENT, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

If you'd like to know more about Intersect ENT as a business, it's important to be aware of any risks it's facing. For example - Intersect ENT has 1 warning sign we think you should be aware of.

If you are no longer interested in Intersect ENT, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.